Remove 2019 Remove Compounding Remove Vaccines
article thumbnail

Key vaccine adjuvant biosynthesised

European Pharmaceutical Review

A paper, published in Nature Chemical Biology has reported the first ‘free-from ‘tree’ production of a key vaccine ingredient sourced from the soapbark tree. Bioengineering vaccine adjuvants The paper explained: “QS-21 is a potent vaccine adjuvant currently sourced by extraction from the Chilean soapbark tree.

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. As of 2019, about 1.9 The first therapy that delays the onset of type 1 diabetes received approval from the U.S.

FDA 98
article thumbnail

Pharmaceutical industry: 2023 in retrospect

European Pharmaceutical Review

Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed. EMA/526934/2019. 21 Similar strategies were applied by FDA and other regulatory agencies. Quality risk management updates.

FDA 111
article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

This was higher than the number of approvals in 2019 and 2020. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.

article thumbnail

Getting on with Rare Disease Therapeutic Options (Orphan Disease Therapies)

PharmaShots

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. With AI-aided research, it becomes relatively easier to select the right compound. Hence, the cost burden comes on the patients and makes drugs expensive for the patient.

FDA 40